NSEGeneral Updates10h ago · 9 Sept 2026, 02:59 pm
General Updates
Sun Pharmaceutical Industries Limited · SUNPHARMA
✦ AI SummaryJoint Venture
Sun Pharmaceutical Industries Limited has informed the Exchange about the incorporation of a subsidiary company, Sun Pharma Global Treasury Centre IFSC Limited, in the International Financial Services Centre at GIFT City, Gandhinagar, Gujarat, India.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sun Pharmaceutical Industries Limited has informed the Exchange about Incorporation of a Subsidiary Company
Attachments (1)
📄pdf
Download →
SUNSEC_09092026145813_SEIntimationforGTCIncorporation.pdf
View document text
Sun Pharmaceutical Industries Limited
Sun House, Plot No. 201 B/1,
Western Express Highway, Goregaon (E),
Mumbai – 400 063, Maharashtra, INDIA.
Tel.: (91-22) 4324 4324
Fax: (91-22) 4324 4343
Website: www.sunpharma.com
Email: secretarial@sunpharma.com
CIN: L24230GJ1993PLC019050
09 September 2026
National Stock Exchange of India Limited BSE Limited
Scrip Symbol: SUNPHARMA Scrip Code: 524715
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 – Incorporation of a Subsidiary Company
This is to inform you that “Sun Pharma Global Treasury Centre IFSC Limited” has been incorporated on 08
September 2026 as an indirect wholly owned subsidiary of the Company in the International Financial Services
Centre at GIFT City, Gandhinagar, Gujarat, India.
The disclosures required under Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure A.
For Sun Pharmaceutical Industries Limited
(Anoop Deshpande)
Company Secretary and Compliance Officer
ICSI Membership No.: A23983
Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA.
Reaching People. Touching Lives.
Sun Pharmaceutical Industries Limited
Sun House, Plot No. 201 B/1,
Western Express Highway, Goregaon (E),
Mumbai – 400 063, Maharashtra, INDIA.
Tel.: (91-22) 4324 4324
Fax: (91-22) 4324 4343
Website: www.sunpharma.com
Email: secretarial@sunpharma.com
CIN: L24230GJ1993PLC019050
Annexure A
Disclosure under Para A of Part A of Schedule III to the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
Sl. No. Particulars Information
a) Name of the target entity, details in brief such as Sun Pharma Global Treasury Centre IFSC
size, turnover etc. Limited, an indirect wholly owned subsidiary
of the Company, incorporated in GIFT City
IFSC, Gandhinagar, Gujarat.
Being newly incorporated, it has not
commenced operations and has no turnover.
b) Whether the acquisition would fall within related The entity has been newly incorporated as a
party transaction(s) and whether the promoter/ wholly owned subsidiary of Sun Pharma
promoter group/ group companies have any Laboratories Limited.
interest in the entity being acquired? If yes, nature
of interest and details thereof and whether the The promoter/promoter group has no interest
same is done at “arm’s length” in the entity except through the Sun Pharma
Group.
c) Industry to which the entity being acquired Financial services, including global treasury
belongs and cash management services.
d) Objects and effects of acquisition (including but To operate as the Global Treasury Centre for
not limited to, disclosure of reasons for the Sun Pharma Group and undertake
acquisition of target entity, if its business is treasury, funding, liquidity, cash management
outside the main line of business of the listed and other permissible financial activities.
entity)
e) Brief details of any governmental or regulatory Registration/approval from the International
approvals required for the acquisition Financial Services Centres Authority will be
obtained for undertaking the proposed
activities in GIFT City IFSC.
f) Indicative time period for completion of the Not applicable, as the entity has been newly
acquisition incorporated.
g) Nature of consideration - whether cash Subscription to the initial equity share capital
consideration or share swap and details of the in cash.
same
h) Cost of acquisition or the price at which the Initial subscription to equity share capital of
shares are acquired approximately INR. 9.50 Crore.
i) Percentage of shareholding/ control acquired and/ 100%, held through Sun Pharma Laboratories
or number of shares acquired Limited, including its nominee shareholders.
j) Brief background about the entity acquired in Incorporated on 08 September 2026 in India
terms of products/line of business acquired, date to operate as the Global Treasury Centre for
of incorporation, history of last 3 years turnover, the Sun Pharma Group. Being newly
country in which the acquired entity has presence incorporated, it has no operating history or
and any other significant information (in brief) turnover.
Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA.
Reaching People. Touching Lives.